Dennis Bourgeault
Chief Financial Officer
Pharmaceutical
The Johns Hopkins University
Canada
Biography
Dennis has been the Chief Financial Officer of the Company since 1998 and is responsible for the financial and administrative operations of the Company. During his tenure, he contributed significantly to one of the largest Canadian biotechnology PIPE transactions, totaling $52 million US dollars and was involved in the multi-million dollar Roche licensing agreement of voclosporin in 2002. In addition, he played a crucial role in executing the merger of Isotechnika and then privately held Aurinia Pharmaceuticals in September 2013. For six years prior to joining Isotechnika, he was the controller for a private industrial distribution company and a Senior Manager in public accounting at KPMG. Dennis obtained his chartered accountant designation in 1984.
Research Interest
Clinical Pharmacy Pharmaceutical Administration Medicinal Chemistry Drug Discovery and Development Pharmaceutical Technology and Biopharmaceutics Pharmaceutical Analysis
